Delivery Order SPE2DB22D3102-SPE2DB25FL2VF
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (30-count units) valued at $20,629.38 under a firm fixed-price contract. The award was made on September 3, 2025, with an ultimate completion date of September 4, 2025, and represents a non-set-aside competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform this delivery order from its corporate office location...
- The Defense Logistics Agency awarded a delivery order valued at $36,331.88 to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (quantity: 30 units) on August 12, 2025, with completion targeted for August 13, 2025. This firm fixed-price contract represents a non-set-aside, competitively awarded procurement of pharmaceutical supplies for federal medical needs. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $17,120.36 to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (30-count units) on September 10, 2025, with completion targeted for September 11, 2025. This firm fixed price delivery order was awarded on a competitive basis with no set-aside designation. The contract performs in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary distribution operations. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $9,905.08 to AmerisourceBergen Drug Corp for the supply of DESCOVY 200-25 mg tablets in quantities of 30 units. This contract, awarded on August 8, 2025, with a completion date of August 11, 2025, represents a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (30-count units) valued at $2,301.40 under a firm fixed-price contract. This non-set-aside delivery order, awarded on September 18, 2025, represents a continuation of pharmaceutical supply fulfillment to support federal military and healthcare operations. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $16,566.76 to AmerisourceBergen Drug Corp for the supply of DESCOVY 200-25 mg tablets in quantities of 30 units. This competitively awarded, firm fixed price delivery order is scheduled for completion by September 12, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The contract contains no set-aside designation and represents a continuation of AmerisourceBergen's substantial pharmaceutical supply...
- The Defense Logistics Agency (DLA) awarded a $26,109.77 delivery order to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (30-count units) with an ultimate completion date of August 18, 2025. This competitively awarded, firm fixed-price contract represents a non-set-aside procurement and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, serves...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $6,442.91 for DESCOVY 200-25 mg tablets in quantities of 30, with a firm fixed price and ultimate completion date of May 28, 2025. This non-set-aside contract was competitively awarded to the pharmaceutical distributor's corporate office in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary operations. This delivery order is issued under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order valued at $9,392.88 to AmerisourceBergen Drug Corp for the supply of DESCOVY 200-25 mg tablets in quantities of 30 units. This firm fixed-price, non-set-aside contract was awarded on August 12, 2025, with an ultimate completion date of August 13, 2025. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,541.35 to AmerisourceBergen Drug Corp for the supply of DESCOVY 200-25 mg tablets in quantities of 30 units. This firm fixed-price delivery order, awarded on August 25, 2025, with an ultimate completion date of August 26, 2025, represents a routine pharmaceutical procurement supporting federal medical supply needs. The contract was competitively awarded with no set-aside designation, and performance will be executed from...
- SPE2DB22D3102Indefinite Delivery Contract
- SPE2DB22D3102-SPE2DB25FL2VFDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $22,737.60 to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (30-count units) under a firm fixed price contract. This delivery order, issued on September 4, 2025, with an ultimate completion date of September 5, 2025, represents a non-competitive set-aside award to support federal pharmaceutical procurement needs. The pharmaceutical product will be performed and distributed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which holds a potential value of $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including medications, vaccines, syringes, and medical devices across multiple therapeutic domains. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen's contract portfolio demonstrates consistent capability in fulfilling diverse healthcare supply requirements for military and veteran healthcare systems through competitive federal procurement processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $22.7k | 9/4/25 |